Nov 8, 2021 · Cumulative incidences of acute graft-versus-host disease (aGvHD) grade II–IV°/chronic GvHD were 11.9%/31%. Nineteen patients (6%) died from DLI- ...
Mar 29, 2022 · Cumulative incidences of acute graft-versus-host disease (aGvHD) grade II–IV°/chronic GvHD were 11.9%/31%. Nineteen patients (6%) died from DLI- ...
Nov 8, 2021 · Cumulative incidences of acute graft-versus-host disease (aGvHD) grade II–IV°/chronic GvHD were 11.9%/31%. Nineteen patients (6%) died from DLI- ...
People also ask
What are the late effects of allogeneic stem cell transplant?
What are the long term complications and side effects after allogeneic hematopoietic stem cell transplantation an update?
What is chronic GVHD after stem cell transplant?
What are the long term side effects of a stem cell transplant?
Jul 25, 2023 · Respective five-year DFS of proDLI patients was 67%, compared to 53% in patients without proDLI due to prior spontaneous GvHD, and 45% in ...
Jan 10, 2024 · Early scheduled pro-DLI achieves higher survival and lower cumulative incidence of relapse, without increasing risk of GVHD and non-relapse mortality.
Oct 15, 2020 · In informative patients, a few severe adverse events were reported: grade III–IV graft versus host disease (GVHD) (3%), grade III–IV ...
Missing: preemptive | Show results with:preemptive
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia. Bone ...
Relapse is the most frequent cause of failure after alloSCT for acute leukemia (AL). Unlike in CML, infusion of donor lymphocytes (DLI) is of limited efficacy ...
Among patients who experienced complete response after combination therapy, 2 year overall survival was 41%, indicating that achieving a response with ...
Mar 7, 2023 · Administration of early DLI resulted in an increased cumulative incidence of moderate to severe GvHD between 3 and 6 months, but only in ...
